ORIGINAL ARTICLE

JOP. J Pancreas (Online) 2008; 9(4):408-414.

Are Health Related Outcomes in Acute Pancreatitis Improving? An Analysis of National Trends in the U.S. from 1997 to 2003

Alphonso Brown1, Benjamin Young1, John Morton2, Kevin Behrns3, Nicholas Shaheen4

1The Beth Israel Deaconess Medical Center, Harvard Medical School. Boston, MA, USA. 2Stanford Hospitals and Clinics, Stanford, CA, USA. 3University of Florida, Gainesville. Gainesville, FL, USA. 4Division of Digestive Diseases, The University of North Carolina at Chapel Hill School of Medicine. Chapel Hill, NC, USA

ABSTRACT

Context Acute pancreatitis is a common inflammatory disorder of the pancreas. Within the past decade our ability to diagnose and treat complications of acute pancreatitis has improved. Despite advances in diagnostic and therapeutic technology it is unclear whether we have been able to impact health related outcomes of acute pancreatitis such as incidence and mortality.

Objective The aim of this study was to use a national database of U.S. hospitals to evaluate the trends in the incidence and mortality associated with acute pancreatitis. We also examined the impact that patient demographic and hospital characteristics have on health related outcomes in acute pancreatitis.

Methods We analyzed the National Inpatient Sample Database (NIS) for all subjects in which acute pancreatitis (ICD-9 code: 577.0) was the principal discharge diagnosis during the period from 1997-2003. All identified subjects were analyzed for demographic characteristics as well as hospital characteristics.

Main outcome measures The mean frequency of discharges for acute pancreatitis, percentage mortality and mean length of stay for acute pancreatitis were determined for all identified cases.

Statistics The statistical significance of the difference in the discharge frequency, mortality and length of stay over the study period was determined by utilization of the chi-square test for trend and the linear regression.

Results During the study period there were 1,476,498 admissions with a principal discharge diagnosis of acute pancreatitis. The frequency of discharges with acute pancreatitis increased by 30.2% (P<0.001) during the period from 1997-2003. The average mortality associated with acute pancreatitis decreased by 35.2% (P<0.001) and the median length of stay decreased by 9.4% (P=0.002). Most discharges with acute pancreatitis were in the Southern U.S. and were at large non-teaching hospitals located in urban areas.

Discussion Possible explanations for the results of our study are the improvements in our ability to diagnose acute pancreatitis, an increase in the availability of medical ICU’s and an increase in hospital admissions for gallstones and alcohol use during the study period.

Full text: HTML format  PDF format

References

  1. Kimura Y, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, et al. JPN Guidelines for the management of acute pancreatitis: treatment of gallstone-induced acute pancreatitis. J Hepatobiliary Pancreat Surg 2006; 13:56-60. [More details]

  2. Tinto A, Lloyd DA, Kang JY, Majeed A, Ellis C, Williamson RC, Maxwell JD. Acute and chronic pancreatitis--diseases on the rise: a study of hospital admissions in England 1989/90-1999/2000. Aliment Pharmacol Ther 2002; 16:2097-105. [More details]

  3. Andersson R, Andersson B, Haraldsen P, Drewsen G, Eckerwall G. Incidence, management and recurrence rate of acute pancreatitis. Scand J Gastroenterol 2004; 39:891-4. [More details]

  4. Corfield AP, Cooper MJ, Williamson RC. Acute pancreatitis: a lethal disease of increasing incidence. Gut 1985; 26:724-9. [More details]

  5. Wilson C, Imrie CW. Deaths from acute pancreatitis: why do we miss the diagnosis so frequently? Int J Pancreatol 1988; 3:273-81. [More details]

  6. Mann DV, Hershman MJ, Hittinger R, Glazer G. Multicentre audit of death from acute pancreatitis. Br J Surg 1994; 81:890-3. [More details]

  7. Fan ST, Choi TK, Lai CS, Wong J. Influence of age on the mortality from acute pancreatitis. Br J Surg 1988; 75:463-6. [More details]

  8. Gullo L, Migliori M, Oláh A, Farkas G, Levy P, Arvanitakis C, et al. Acute pancreatitis in five European countries: etiology and mortality. Pancreas 2002; 24:223-7. [More details]

  9. Kim CD. Current status of acute pancreatitis in Korea. Korean J Gastroenterol 2003; 42:1-11. [More details]

  10. Lowenfels AB, Maisonneuve P, Grover H, Gerber E, Korsten MA, Antunes MT, et al. Racial factors and the risk of chronic pancreatitis. Am J Gastroenterol 1999; 94:790-4. [More details]

  11. Talamini G, Bassi C, Falconi M, Sartori N, Frulloni L, Di Francesco V, et al. Risk of death from acute pancreatitis. Role of early, simple "routine" data. Int J Pancreatol 1996; 19:15-24. [More details]

  12. Lowham A, Lavelle J, Leese T. Mortality from acute pancreatitis. Late septic deaths can be avoided but some early deaths still occur. Int J Pancreatol 1999; 25:103-6. [More details]

  13. Mutinga M, Rosenbluth A, Tenner SM, Odze RR, Sica GT, Banks PA. Does mortality occur early or late in acute pancreatitis? Int J Pancreatol 2000; 28:91-5. [More details]

  14. Blum T, Maisonneuve P, Lowenfels AB, Lankisch PG. Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology 2001; 1:237-41. [More details]

  15. Kandasami P, Harunarashid H, Kaur H. Acute pancreatitis in a multi-ethnic population. Singapore Med J 2002; 43:284-8. [More details]

  16. Ma XX, Galiana A, Pedreira W, Mowszowicz M, Christophersen I, Machiavello S, et al. Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg Infect Dis 2005; 1:973-6. [More details]

  17. Lankisch PG, Assmus C, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic diseases in Lüneburg County. A study in a defined german population. Pancreatology 2002; 2:469-77. [More details]

  18. Floyd A, Pedersen L, Nielsen GL, Thorladcius-Ussing O, Sorensen HT. Secular trends in incidence and 30-day case fatality of acute pancreatitis in North Jutland County, Denmark: a register-based study from 1981-2000. Scand J Gastroenterol 2002; 37:1461-5. [More details]

  19. Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand JA, et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 2004; 32:2524-36. [More details]

  20. Halpern NA, Pastores SM, Greenstein RJ. Critical care medicine in the United States 1985-2000: an analysis of bed numbers, use, and costs. Crit Care Med 2004; 32:1254-9. [More details]

  21. Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, McKay C, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001; 48:62-9. [More details]

  22. Ogawa M, Hirota M, Hayakawa T, Matsuno S, Watanabe S, Atomi Y, et al. Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan. Pancreas 2002; 25:325-30. [More details]

Keywords Epidemiology; Mortality; Pancreatitis, Acute Necrotizing; United States

Correspondence Alphonso Brown: abrown4@bidmc.harvard.edu

JOP Home page